• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2型疾病辅助疗法及补充剂在感染预防方面取得突破。

SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention.

作者信息

Inchingolo Alessio Danilo, Inchingolo Angelo Michele, Bordea Ioana Roxana, Malcangi Giuseppina, Xhajanka Edit, Scarano Antonio, Lorusso Felice, Farronato Marco, Tartaglia Gianluca Martino, Isacco Ciro Gargiulo, Marinelli Grazia, D'Oria Maria Teresa, Hazballa Denisa, Santacroce Luigi, Ballini Andrea, Contaldo Maria, Inchingolo Francesco, Dipalma Gianna

机构信息

Department of Interdisciplinary Medicine, University of Medicine Aldo Moro, 70124 Bari, Italy.

Department of Oral Rehabilitation, Faculty of Dentistry, Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

出版信息

Microorganisms. 2021 Mar 4;9(3):525. doi: 10.3390/microorganisms9030525.

DOI:10.3390/microorganisms9030525
PMID:33806624
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7999785/
Abstract

The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a high-risk viral agent involved in the recent pandemic stated worldwide by the World Health Organization. The infection is correlated to a severe systemic and respiratory disease in many cases, which is clinically treated with a multi-drug pharmacological approach. The purpose of this investigation was to evaluate through a literature overview the effect of adjuvant therapies and supplements for the SARS-CoV-2 infection. The research has analyzed the advantage of the EK1C4, by also assessing the studies on the resveratrol, vitamin D, and melatonin as adjuvant supplements for long hauler patients' prognosis. The evaluated substances reported important benefits for the improvement of the immune system and as a potential inhibitor molecules against SARS-CoV-2, highlighting the use of sartans as therapy. The adjuvant supplements seem to create an advantage for the healing of the long hauler patients affected by chronic symptoms of constant chest and heart pain, intestinal disorders, headache, difficulty concentrating, memory loss, and tachycardia.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是一种高风险病毒病原体,世界卫生组织称其引发了近期全球大流行。在许多情况下,该感染与严重的全身性和呼吸道疾病相关,临床上采用多种药物的药理学方法进行治疗。本研究的目的是通过文献综述评估辅助疗法和补充剂对SARS-CoV-2感染的影响。该研究分析了EK1C4的优势,同时还评估了白藜芦醇、维生素D和褪黑素作为辅助补充剂对长期康复患者预后的研究。评估的物质显示出对改善免疫系统以及作为对抗SARS-CoV-2的潜在抑制剂分子具有重要益处,突出了使用沙坦类药物作为治疗方法。辅助补充剂似乎为患有持续胸痛、心痛、肠道疾病、头痛、注意力不集中、记忆力减退和心动过速等慢性症状的长期康复患者的康复创造了优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d315/7999785/8f9f9065fcb9/microorganisms-09-00525-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d315/7999785/5d8394738fa1/microorganisms-09-00525-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d315/7999785/e572bc397151/microorganisms-09-00525-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d315/7999785/fe79eb858e02/microorganisms-09-00525-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d315/7999785/0837007257be/microorganisms-09-00525-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d315/7999785/8f9f9065fcb9/microorganisms-09-00525-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d315/7999785/5d8394738fa1/microorganisms-09-00525-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d315/7999785/e572bc397151/microorganisms-09-00525-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d315/7999785/fe79eb858e02/microorganisms-09-00525-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d315/7999785/0837007257be/microorganisms-09-00525-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d315/7999785/8f9f9065fcb9/microorganisms-09-00525-g005.jpg

相似文献

1
SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention.严重急性呼吸综合征冠状病毒2型疾病辅助疗法及补充剂在感染预防方面取得突破。
Microorganisms. 2021 Mar 4;9(3):525. doi: 10.3390/microorganisms9030525.
2
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
3
The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.维生素D代谢作为COVID-19潜在的预防性、免疫调节性和神经保护性治疗的重要性。
J Transl Med. 2020 Aug 26;18(1):322. doi: 10.1186/s12967-020-02488-5.
4
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.SARS-CoV、MERS-CoV 和 SARS-CoV-2 感染中的免疫致病反应和血液病理效应的重点。
Front Immunol. 2020 May 12;11:1022. doi: 10.3389/fimmu.2020.01022. eCollection 2020.
5
SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs.基于病毒基因组和受体影响的2019冠状病毒病:诊断与免疫学突破概述
Microorganisms. 2021 Apr 10;9(4):793. doi: 10.3390/microorganisms9040793.
6
Pilot study for the evaluation of safety profile of a potential inhibitor of SARS-CoV-2 endocytosis.一项评估新型冠状病毒内吞作用潜在抑制剂安全性的初步研究。
Acta Biomed. 2020 Nov 9;91(13-S):e2020009. doi: 10.23750/abm.v91i13-S.10583.
7
Monoclonal Antibody Therapy For High-Risk Coronavirus (COVID 19) Patients With Mild To Moderate Disease Presentations (Archived)针对轻度至中度症状的高危冠状病毒(COVID-19)患者的单克隆抗体疗法(存档)
8
Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination.多发性硬化症的疾病修正治疗与 COVID-19 大流行:感染风险和未来疫苗接种的影响。
CNS Drugs. 2020 Sep;34(9):879-896. doi: 10.1007/s40263-020-00756-y.
9
Dietary Supplements for COVID-19.用于 COVID-19 的膳食补充剂。
Adv Exp Med Biol. 2021;1318:499-515. doi: 10.1007/978-3-030-63761-3_29.
10
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.托珠单抗治疗细胞因子风暴综合征的 SARS-CoV-2 患者:一项叙述性综述。
Rev Recent Clin Trials. 2021;16(2):138-145. doi: 10.2174/1574887115666200917110954.

引用本文的文献

1
The Gut Microbiota's Role in Neurological, Psychiatric, and Neurodevelopmental Disorders.肠道微生物群在神经、精神和神经发育障碍中的作用。
Nutrients. 2024 Dec 22;16(24):4404. doi: 10.3390/nu16244404.
2
Role of MR-proADM and Monocyte CD169 in Predicting In-Hospital and 60-Day Mortality in COVID-19 Patients.MR-proADM和单核细胞CD169在预测COVID-19患者住院及60天死亡率中的作用
Clin Pathol. 2024 Dec 16;17:2632010X241304958. doi: 10.1177/2632010X241304958. eCollection 2024 Jan-Dec.
3
Stem Cells: Present Understanding and Prospects for Regenerative Dentistry.

本文引用的文献

1
Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial.连花清瘟胶囊治疗新型冠状病毒肺炎有效性和安全性的多中心前瞻性随机对照临床试验
Phytomedicine. 2021 May;85:153242. doi: 10.1016/j.phymed.2020.153242. Epub 2020 May 16.
2
Protective Face Masks: Effect on the Oxygenation and Heart Rate Status of Oral Surgeons during Surgery.防护面罩对口腔外科医生手术中氧合和心率状态的影响。
Int J Environ Res Public Health. 2021 Feb 28;18(5):2363. doi: 10.3390/ijerph18052363.
3
Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people.
干细胞:目前对再生牙科的认识与前景
J Funct Biomater. 2024 Oct 15;15(10):308. doi: 10.3390/jfb15100308.
4
Management of Patients Receiving Anticoagulation Therapy in Dental Practice: A Systematic Review.牙科实践中接受抗凝治疗患者的管理:一项系统评价。
Healthcare (Basel). 2024 Aug 2;12(15):1537. doi: 10.3390/healthcare12151537.
5
The Antimicrobial Activity of Combination of Vitamin D3 and Omega-3 against Pathogenic Microorganisms.维生素D3与Omega-3联合对致病微生物的抗菌活性
Comb Chem High Throughput Screen. 2025;28(8):1278-1289. doi: 10.2174/0113862073293834240425061327.
6
Benefits of Natural Antioxidants on Oral Health.天然抗氧化剂对口腔健康的益处。
Antioxidants (Basel). 2023 Jun 20;12(6):1309. doi: 10.3390/antiox12061309.
7
Damage from Carbonated Soft Drinks on Enamel: A Systematic Review.碳酸软饮料对牙釉质损害的系统评价
Nutrients. 2023 Apr 6;15(7):1785. doi: 10.3390/nu15071785.
8
The Management of Obstructive Sleep Apnea Patients during the COVID-19 Pandemic as a Public Health Problem-Interactions with Sleep Efficacy and Mental Health.COVID-19 大流行期间阻塞性睡眠呼吸暂停患者的管理作为公共卫生问题-与睡眠功效和心理健康的相互作用。
Int J Environ Res Public Health. 2023 Feb 28;20(5):4313. doi: 10.3390/ijerph20054313.
9
Inflammation as Prognostic Hallmark of Clinical Outcome in Patients with SARS-CoV-2 Infection.炎症作为新型冠状病毒肺炎患者临床结局的预后标志
Life (Basel). 2023 Jan 23;13(2):322. doi: 10.3390/life13020322.
10
Diagnosis of SARS-CoV-2 during the Pandemic by Multiplex RT-rPCR hCoV Test: Future Perspectives.多重逆转录实时聚合酶链反应人冠状病毒检测在大流行期间对严重急性呼吸综合征冠状病毒2的诊断:未来展望
Pathogens. 2022 Nov 18;11(11):1378. doi: 10.3390/pathogens11111378.
新型SARS-CoV-2变体B.1.1.7对儿童和年轻人的影响。
Lancet Child Adolesc Health. 2021 Apr;5(4):e9-e10. doi: 10.1016/S2352-4642(21)00030-4. Epub 2021 Feb 10.
4
What we have learned for the future about COVID-19 and healthcare management of it?对于未来的 COVID-19 疫情,以及对其进行的医疗保健管理,我们有什么了解?
Acta Biomed. 2020 Jul 22;91(4):e2020126. doi: 10.23750/abm.v91i4.10253.
5
An Alternative "Trojan Horse" Hypothesis for COVID-19: Immune Deficiency of IL-10 and SARS-CoV-2 Biology.新冠病毒的另一种“特洛伊木马”假说:IL-10 免疫缺陷与 SARS-CoV-2 生物学。
Endocr Metab Immune Disord Drug Targets. 2022;22(1):1-5. doi: 10.2174/1871530321666210127141945.
6
From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy.从血管紧张素 II 到环肽和血管紧张素受体阻滞剂 (ARB):ARB 在 COVID-19 治疗中的观点。
Molecules. 2021 Jan 25;26(3):618. doi: 10.3390/molecules26030618.
7
Clinical and diagnostic findings in COVID-19 patients: an original research from SG Moscati Hospital in Taranto Italy.意大利塔兰托 SG Moscati 医院的 COVID-19 患者的临床和诊断结果:一项原创研究。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):171-183. doi: 10.23812/20-605-A.
8
Potential beneficial role of probiotics on the outcome of COVID-19 patients: An evolving perspective.益生菌对 COVID-19 患者结局的潜在有益作用:不断发展的观点。
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):295-301. doi: 10.1016/j.dsx.2020.12.040. Epub 2021 Jan 13.
9
Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection.新型冠状病毒肺炎患者淋巴细胞中的自噬调节:严重急性呼吸综合征冠状病毒2感染的新治疗靶点
Front Pharmacol. 2020 Nov 19;11:569849. doi: 10.3389/fphar.2020.569849. eCollection 2020.
10
Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore.商用漱口水对唾液中SARS-CoV-2病毒载量的疗效:新加坡的随机对照试验
Infection. 2021 Apr;49(2):305-311. doi: 10.1007/s15010-020-01563-9. Epub 2020 Dec 14.